Company intelligence / Profile preview

CannaNova

Greensboro, North Carolina, United Stateskatob427.com ↗

Ownership: Private
Development stage: Commercial

Overview

CannaNova has developed and commercialized a proprietary oral film technology (DepoFilm™) for rapid-onset, buccal delivery of cannabinoids. The company addresses key challenges with traditional edibles such as slow onset and inconsistent bioavailability by offering dissolving thin films for adult consumers[1][2].

Therapeutic areas: Psychiatry
Modalities: Small moleculeFilm-based drug delivery
Industry: Food & Nutrition

Drug pipeline

1 asset

Delta-8 THC

Commercial

Beyond the preview

Go deeper on CannaNova.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CannaNova.

Explore the full profile